1
|
WHO-EORTC classification for cutaneous lymphomas.
|
Blood
|
2005
|
12.14
|
2
|
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
|
Blood
|
2007
|
4.36
|
3
|
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.
|
J Clin Oncol
|
2011
|
1.85
|
4
|
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
|
Blood
|
2008
|
1.73
|
5
|
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
|
J Clin Oncol
|
2006
|
1.70
|
6
|
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
|
Blood
|
2011
|
1.64
|
7
|
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.
|
J Cutan Pathol
|
2005
|
1.51
|
8
|
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
|
Eur J Cancer
|
2006
|
1.38
|
9
|
TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).
|
Blood
|
2007
|
1.35
|
10
|
Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
|
Stem Cells
|
2012
|
1.26
|
11
|
Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
|
Haematologica
|
2008
|
1.20
|
12
|
Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions.
|
Am J Pathol
|
2004
|
1.16
|
13
|
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
|
Cancer
|
2003
|
1.15
|
14
|
New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use.
|
Am J Clin Dermatol
|
2002
|
1.11
|
15
|
Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response.
|
Biol Blood Marrow Transplant
|
2009
|
1.07
|
16
|
Skin cancer and immunosuppression.
|
Crit Rev Oncol Hematol
|
2005
|
1.04
|
17
|
Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy.
|
Clin Exp Metastasis
|
2012
|
0.97
|
18
|
Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors.
|
Clin Cancer Res
|
2010
|
0.96
|
19
|
Spectral morphological analysis of skin lesions with a polarization multispectral dermoscope.
|
Opt Express
|
2013
|
0.96
|
20
|
Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type.
|
J Invest Dermatol
|
2008
|
0.94
|
21
|
Massive recruitment of type I interferon producing plasmacytoid dendritic cells in varicella skin lesions.
|
J Invest Dermatol
|
2006
|
0.94
|
22
|
Expression of Notch-1 and alteration of the E-cadherin/beta-catenin cell adhesion complex are observed in primary cutaneous neuroendocrine carcinoma (Merkel cell carcinoma).
|
Mod Pathol
|
2009
|
0.92
|
23
|
A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation.
|
J Immunol
|
2007
|
0.92
|
24
|
Lamina propria dendritic cells express activation markers and contact lymphocytes in chronic periodontitis.
|
J Periodontol
|
2002
|
0.91
|
25
|
Primary cutaneous B-cell lymphomas. Current concepts. I.
|
Haematologica
|
2004
|
0.91
|
26
|
Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment.
|
J Infect
|
2012
|
0.89
|
27
|
Induction of CD83+CD14+ nondendritic antigen-presenting cells by exposure of monocytes to IFN-alpha.
|
J Immunol
|
2008
|
0.89
|
28
|
Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes.
|
Clin Immunol
|
2007
|
0.88
|
29
|
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
|
Cancer
|
2005
|
0.88
|
30
|
Role of conventional treatments on circulating and monocyte-derived dendritic cells in colorectal cancer.
|
Clin Immunol
|
2006
|
0.87
|
31
|
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
|
Cancer
|
2012
|
0.87
|
32
|
Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas.
|
Haematologica
|
2007
|
0.86
|
33
|
Relationship between Latitude and Melanoma in Italy.
|
ISRN Oncol
|
2012
|
0.82
|
34
|
Surgical management of suspicious melanocytic lesions in Italy.
|
Dermatology
|
2013
|
0.82
|
35
|
Role of bexarotene in the treatment of cutaneous T-cell lymphoma: the clinical and immunological sides.
|
Immunotherapy
|
2013
|
0.81
|
36
|
Photoexposition discriminates Notch 1 expression in human cutaneous squamous cell carcinoma.
|
Mod Pathol
|
2008
|
0.81
|
37
|
Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin.
|
Hum Pathol
|
2003
|
0.81
|
38
|
Indoleamine 2,3-dioxygenase+ cells correspond to the BDCA2+ plasmacytoid dendritic cells in human melanoma sentinel nodes.
|
J Invest Dermatol
|
2009
|
0.81
|
39
|
Chronic hepatitis C virus hepatitis and psoriasis: no longer a contraindication to interferon use in the era of biological agents?
|
Scand J Infect Dis
|
2012
|
0.81
|
40
|
Human Langerhans cells are immature in melanoma sentinel lymph nodes.
|
Blood
|
2012
|
0.80
|
41
|
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.
|
Eur J Haematol
|
2009
|
0.80
|
42
|
Primary cutaneous lymphomas: a reprisal.
|
Semin Diagn Pathol
|
2011
|
0.79
|
43
|
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme.
|
Oncotarget
|
2014
|
0.79
|
44
|
Monochromatic excimer light (308 nm) in patch-stage IA mycosis fungoides.
|
J Am Acad Dermatol
|
2004
|
0.79
|
45
|
Stem cell factor affects tumour progression markers in metastatic melanoma cells.
|
Clin Exp Metastasis
|
2006
|
0.79
|
46
|
Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy.
|
Histopathology
|
2011
|
0.78
|
47
|
Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon.
|
J Chemother
|
2013
|
0.78
|
48
|
Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
|
Eur J Haematol
|
2014
|
0.77
|
49
|
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells.
|
J Mol Med (Berl)
|
2015
|
0.77
|
50
|
Acute leucocytoclastic vasculitis and aquagenic pruritus long preceding polycythemia rubra vera.
|
Eur J Dermatol
|
2002
|
0.77
|
51
|
Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study.
|
J Am Acad Dermatol
|
2006
|
0.76
|
52
|
Contacts between mast cells and dendritic cells in the human skin.
|
Ital J Anat Embryol
|
2010
|
0.76
|
53
|
Combined fluorescence-Raman spectroscopic setup for the diagnosis of melanocytic lesions.
|
J Biophotonics
|
2013
|
0.76
|
54
|
Laser surgery in rhinophyma.
|
G Ital Dermatol Venereol
|
2014
|
0.75
|
55
|
Atypical CD30+ cutaneous lymphoid proliferation in a patient with tuberculosis infection.
|
Am J Dermatopathol
|
2004
|
0.75
|
56
|
Body image and awareness in patients with advanced-stage melanoma.
|
G Ital Dermatol Venereol
|
2015
|
0.75
|
57
|
Diagnostic services for melanoma in Italy.
|
Dermatology
|
2013
|
0.75
|
58
|
[Solar ultraviolet radiation risk in outdoor workers: a specific project of Tuscany Region (Italy)].
|
Epidemiol Prev
|
2013
|
0.75
|
59
|
Impact of mole mapping in the Italian health system.
|
Dermatology
|
2013
|
0.75
|
60
|
Annular lichen planus on the mammary areola: an unusual localization.
|
G Ital Dermatol Venereol
|
2016
|
0.75
|
61
|
Melanoma density and relationship with the distribution of melanocytic naevi in an Italian population: a GIPMe study--the Italian multidisciplinary group on melanoma.
|
Melanoma Res
|
2015
|
0.75
|
62
|
Management of small and intermediate congenital nevi: a nationwide survey in Italy.
|
Dermatology
|
2013
|
0.75
|
63
|
Early activation of fibroblasts during PDT treatment in leg ulcers.
|
G Ital Dermatol Venereol
|
2014
|
0.75
|
64
|
An Asymptomatic Plaque on the Chest: A Quiz.
|
Acta Derm Venereol
|
2017
|
0.75
|
65
|
Animal-type melanoma: report of five cases with sentinel node biopsy and fluorescence in-situ hybridization analysis.
|
Melanoma Res
|
2014
|
0.75
|
66
|
Erythema ab igne.
|
Intern Emerg Med
|
2010
|
0.75
|
67
|
Melanoma survival: sex does matter, but we do not know how.
|
Eur J Cancer Prev
|
2016
|
0.75
|